Brian Sumner, MD

Residency: Mount Sinai Morningside - West
Medical school: George Washington University School of Medicine and Health Sciences

The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.
Originally designed for use in rheumatoid arthritis, tocilizumab is being considered as a potential therapeutic agent to treat COVID-19.
While much is still left to be known about COVID-19, research has supported the theory that an excessive host inflammatory response is responsible for much of the morbidity and mortality seen by the d
Does treatment with vitamin C, thiamine, and hydrocortisone lead to an increase in the number of days alive and free of mechanical ventilation and vasopressor use? The latest EMRA Critical Care Alert
The latest EMRA Critical Care Alert examines a study that questions whether ultra-short-acting beta-blockers, such as esmolol and landiolol, reduced 28-day mortality in septic patients with persistent
Two recent papers offer insight into the use of peripheral IVs to administer vasopressors. Will these studies change your practice for critically ill patients in the emergency department?
Fluid overload has not been clearly defined in the critical care arena. In situations where patients have renal, cardiac, and pulmonary dysfunction, commonly seen in the ICU, large volume fluid therap
The role of corticosteroids in severe infections, sepsis and ARDS has been a constantly evolving discussion and remains controversial. The recent APROCCHSs, ADRENAL and DEXA-ARDS along with other prio
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening form of respiratory failure characterized by massive inflammation leading to pulmonary edema, decruitment of alveoli, and hypoxemia. De
A complex trial meant to determine whether hydrocortisone can improve outcomes for patients with severe COVID-19 was stopped early - but still shows promise for the course.
CHAT NOW
CHAT OFFLINE